205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Negative revenue growth while NXPI stands at 2.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.13%
Negative gross profit growth while NXPI is at 2.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.11%
Negative EBIT growth while NXPI is at 28.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.58%
Negative operating income growth while NXPI is at 28.83%. Joel Greenblatt would press for urgent turnaround measures.
-73.23%
Negative net income growth while NXPI stands at 597.22%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while NXPI is at 587.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while NXPI is at 600.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Share reduction while NXPI is at 1.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.10%
Reduced diluted shares while NXPI is at 0.30%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
23.81%
Dividend growth of 23.81% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
12.02%
OCF growth at 75-90% of NXPI's 14.77%. Bill Ackman would demand better working capital management or cost discipline.
10.55%
FCF growth under 50% of NXPI's 27.96%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.89%
10Y revenue/share CAGR 1.25-1.5x NXPI's 33.11%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
42.24%
5Y revenue/share CAGR at 50-75% of NXPI's 59.87%. Martin Whitman would worry about a lagging mid-term growth trajectory.
21.89%
3Y revenue/share CAGR above 1.5x NXPI's 8.54%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
88.82%
10Y OCF/share CAGR under 50% of NXPI's 1919.01%. Michael Burry would worry about a persistent underperformance in cash creation.
100.89%
Below 50% of NXPI's 226.90%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.14%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
-36.54%
Negative 10Y net income/share CAGR while NXPI is at 226.01%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
Below 50% of NXPI's 571.56%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-55.69%
Negative 3Y CAGR while NXPI is 243.28%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
Below 50% of NXPI's 815.23%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.56%
Below 50% of NXPI's 836.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of NXPI's 1607.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
Dividend/share CAGR of 516.71% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.79%
Dividend/share CAGR of 193.79% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.37%
3Y dividend/share CAGR of 82.37% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-18.91%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.57%
Inventory growth well above NXPI's 2.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.21%
Asset growth above 1.5x NXPI's 1.08%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-5.64%
We have a declining book value while NXPI shows 4.52%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
Debt growth far above NXPI's 0.14%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.93%
R&D growth drastically higher vs. NXPI's 5.61%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.73%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.